Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report

Diabetic macular edema (DME) is now a well-known condition for which a number of treatments have been shown to be effective. Intraocular corticosteroids are part of this therapeutic arsenal but are sometimes responsible for ocular hypertension. We describe here the case of a 60-year-old man with a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezkallah, Amina, Loria, Olivier, Mathis, Thibaud, Chacun, Samuel, Denis, Philippe, Kodjikian, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808306/
https://www.ncbi.nlm.nih.gov/pubmed/36605048
http://dx.doi.org/10.1159/000527672
_version_ 1784862912849903616
author Rezkallah, Amina
Loria, Olivier
Mathis, Thibaud
Chacun, Samuel
Denis, Philippe
Kodjikian, Laurent
author_facet Rezkallah, Amina
Loria, Olivier
Mathis, Thibaud
Chacun, Samuel
Denis, Philippe
Kodjikian, Laurent
author_sort Rezkallah, Amina
collection PubMed
description Diabetic macular edema (DME) is now a well-known condition for which a number of treatments have been shown to be effective. Intraocular corticosteroids are part of this therapeutic arsenal but are sometimes responsible for ocular hypertension. We describe here the case of a 60-year-old man with a history of bilateral DME who received an intravitreal injection of 190 µg fluocinolone acetonide (FAc) (ILUVIEN(®), Alimera Sciences, Alpharetta, GA, USA) who presented a persistent ocular hypertension in one eye despite FAc removal by pars plana vitrectomy and was successfully managed by Preserflo(®) microshunt surgery.
format Online
Article
Text
id pubmed-9808306
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-98083062023-01-04 Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report Rezkallah, Amina Loria, Olivier Mathis, Thibaud Chacun, Samuel Denis, Philippe Kodjikian, Laurent Case Rep Ophthalmol Case Report Diabetic macular edema (DME) is now a well-known condition for which a number of treatments have been shown to be effective. Intraocular corticosteroids are part of this therapeutic arsenal but are sometimes responsible for ocular hypertension. We describe here the case of a 60-year-old man with a history of bilateral DME who received an intravitreal injection of 190 µg fluocinolone acetonide (FAc) (ILUVIEN(®), Alimera Sciences, Alpharetta, GA, USA) who presented a persistent ocular hypertension in one eye despite FAc removal by pars plana vitrectomy and was successfully managed by Preserflo(®) microshunt surgery. The Author(s). Published by S. Karger AG 2022-12-16 /pmc/articles/PMC9808306/ /pubmed/36605048 http://dx.doi.org/10.1159/000527672 Text en © 2022 The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Rezkallah, Amina
Loria, Olivier
Mathis, Thibaud
Chacun, Samuel
Denis, Philippe
Kodjikian, Laurent
Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report
title Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report
title_full Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report
title_fullStr Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report
title_full_unstemmed Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report
title_short Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report
title_sort preserflo microshunt surgery for ocular hypertension following intravitreal fluocinolone acetonide implant removal: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808306/
https://www.ncbi.nlm.nih.gov/pubmed/36605048
http://dx.doi.org/10.1159/000527672
work_keys_str_mv AT rezkallahamina preserflomicroshuntsurgeryforocularhypertensionfollowingintravitrealfluocinoloneacetonideimplantremovalacasereport
AT loriaolivier preserflomicroshuntsurgeryforocularhypertensionfollowingintravitrealfluocinoloneacetonideimplantremovalacasereport
AT mathisthibaud preserflomicroshuntsurgeryforocularhypertensionfollowingintravitrealfluocinoloneacetonideimplantremovalacasereport
AT chacunsamuel preserflomicroshuntsurgeryforocularhypertensionfollowingintravitrealfluocinoloneacetonideimplantremovalacasereport
AT denisphilippe preserflomicroshuntsurgeryforocularhypertensionfollowingintravitrealfluocinoloneacetonideimplantremovalacasereport
AT kodjikianlaurent preserflomicroshuntsurgeryforocularhypertensionfollowingintravitrealfluocinoloneacetonideimplantremovalacasereport

Ejemplares similares